EyePoint, Inc. (EYPT)
3.99
+0.54
(+15.65%)
USD |
NASDAQ |
Sep 17, 16:00
3.97
-0.02
(-0.50%)
After-Hours: 07:06
EyePoint 30-Day Average Daily Volume : 5.840M for Sept. 17, 2026
30-Day Average Daily Volume Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| September 17, 2026 | 5.840M |
| September 16, 2026 | 5.689M |
| September 15, 2026 | 5.621M |
| September 14, 2026 | 5.541M |
| September 11, 2026 | 5.514M |
| September 10, 2026 | 5.475M |
| September 09, 2026 | 5.399M |
| September 08, 2026 | 5.356M |
| September 04, 2026 | 5.327M |
| September 03, 2026 | 5.313M |
| September 02, 2026 | 5.268M |
| September 01, 2026 | 5.146M |
| August 31, 2026 | 5.090M |
| August 28, 2026 | 5.010M |
| August 27, 2026 | 4.906M |
| August 26, 2026 | 4.758M |
| August 25, 2026 | 4.699M |
| August 24, 2026 | 4.597M |
| August 21, 2026 | 4.495M |
| August 20, 2026 | 4.277M |
| August 19, 2026 | 4.083M |
| August 18, 2026 | 3.853M |
| August 17, 2026 | 3.382M |
| August 14, 2026 | 1.693M |
| August 13, 2026 | 1.659M |
| Date | Value |
|---|---|
| August 12, 2026 | 1.691M |
| August 11, 2026 | 1.693M |
| August 10, 2026 | 1.677M |
| August 07, 2026 | 1.736M |
| August 06, 2026 | 1.723M |
| August 05, 2026 | 1.678M |
| August 04, 2026 | 1.648M |
| August 03, 2026 | 1.579M |
| July 31, 2026 | 1.572M |
| July 30, 2026 | 1.555M |
| July 29, 2026 | 1.552M |
| July 28, 2026 | 1.519M |
| July 27, 2026 | 1.499M |
| July 24, 2026 | 1.495M |
| July 23, 2026 | 1.485M |
| July 22, 2026 | 1.504M |
| July 21, 2026 | 1.496M |
| July 20, 2026 | 1.474M |
| July 17, 2026 | 1.464M |
| July 16, 2026 | 1.449M |
| July 15, 2026 | 1.431M |
| July 14, 2026 | 1.425M |
| July 13, 2026 | 1.425M |
| July 10, 2026 | 1.435M |
| July 09, 2026 | 1.441M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Ocular Therapeutix, Inc. | 2.594M |
| Eli Lilly & Co. | 2.402M |
| Elanco Animal Health, Inc. | 6.877M |
| Amylyx Pharmaceuticals, Inc. | 3.086M |
| Nuvation Bio, Inc. | 5.406M |